Literature DB >> 9432025

Interdonor variability of platelet response to thrombin receptor activation: influence of PlA2 polymorphism.

D Lasne1, M Krenn, V Pingault, E Arnaud, J N Fiessinger, M Aiach, F Rendu.   

Abstract

Considering that platelet response to thrombin receptor activation might be critical for the development of arterial thrombosis, we measured the dense granule release under stimulation by the thrombin receptor activating peptide (TRAP) in a series of 102 healthy volunteers. The threshold TRAP concentration which initiated a secretion ranged from 3 to 20 microM. A good concordance (79%, k=0.677) between two tests performed at a 1 month interval indicated that platelet response to thrombin receptor activation was characteristic of each individual donor. Since the threshold concentration required to initiate secretion corresponded to the threshold concentration which induced a biphasic aggregation, all volunteers were genotyped for the PlA2 polymorphism, the Pro33 variant of GPIIIa. Platelets from subjects with the PlA2 polymorphism required higher TRAP concentrations to aggregate than those from subjects with no PlA2 allele (P=0.0012). However, they also required a higher ADP concentration to aggregate. In order to exclude any influence of GPIIIa polymorphism on TRAP-induced secretion, we studied the variability of platelet response to TRAP among the 77 individuals with no PlA2 allele, and found the same interdonor variability with the same distribution of threshold TRAP concentrations as for the 102 individuals. The results suggest that (i) platelet secretion in response to thrombin receptor activation could be a genetically controlled phenotype independent of the GPIIIa polymorphism; (ii) the PlA2 polymorphism is associated with platelet hypoaggregability.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9432025     DOI: 10.1046/j.1365-2141.1997.4973300.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  The Pl(A2) allele and cardiovascular disease: the pro(33) and con.

Authors:  T V Byzova; E F Plow
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

Review 2.  The genetics of normal platelet reactivity.

Authors:  Thomas J Kunicki; Diane J Nugent
Journal:  Blood       Date:  2010-07-07       Impact factor: 22.113

Review 3.  Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions.

Authors:  Anetta Undas; Kathleen E Brummel-Ziedins; Kenneth G Mann
Journal:  Blood       Date:  2006-12-05       Impact factor: 22.113

4.  Aggregometry detects platelet hyperreactivity in healthy individuals.

Authors:  Donald L Yee; Carol W Sun; Angela L Bergeron; Jing-Fei Dong; Paul F Bray
Journal:  Blood       Date:  2005-06-21       Impact factor: 22.113

Review 5.  Pharmacogenetics of aspirin resistance: a comprehensive systematic review.

Authors:  Timothy Goodman; Albert Ferro; Pankaj Sharma
Journal:  Br J Clin Pharmacol       Date:  2008-04-22       Impact factor: 4.335

6.  Evaluation of the F2R IVS-14A/T PAR1 polymorphism with subsequent cardiovascular events and bleeding in patients who have undergone percutaneous coronary intervention.

Authors:  Eitan A Friedman; Luisa Texeira; Jessica Delaney; Peter E Weeke; Donald R Lynch; Ehab Kasasbeh; Yanna Song; Frank E Harrell; Josh C Denny; Heidi E Hamm; Dan M Roden; John H Cleator
Journal:  J Thromb Thrombolysis       Date:  2016-05       Impact factor: 2.300

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.